275 related articles for article (PubMed ID: 30230592)
1. Long noncoding RNA DGCR5 represses hepatocellular carcinoma progression by inactivating Wnt signaling pathway.
Wang XL; Shi M; Xiang T; Bu YZ
J Cell Biochem; 2019 Jan; 120(1):275-282. PubMed ID: 30230592
[TBL] [Abstract][Full Text] [Related]
2. LncRNA DGCR5 represses the development of hepatocellular carcinoma by targeting the miR-346/KLF14 axis.
Wang YG; Liu J; Shi M; Chen FX
J Cell Physiol; 2018 Jan; 234(1):572-580. PubMed ID: 30216442
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of long noncoding RNA DGCR5 contributes to the proliferation, migration, and invasion of cervical cancer by activating Wnt signaling pathway.
Liu Y; Chang Y; Lu S; Xiang YY
J Cell Physiol; 2019 Jul; 234(7):11662-11669. PubMed ID: 30552671
[TBL] [Abstract][Full Text] [Related]
4. LINC01133 aggravates the progression of hepatocellular carcinoma by activating the PI3K/AKT pathway.
Zheng YF; Zhang XY; Bu YZ
J Cell Biochem; 2019 Mar; 120(3):4172-4179. PubMed ID: 30548306
[TBL] [Abstract][Full Text] [Related]
5. LncRNA RUNX1-IT1 which is downregulated by hypoxia-driven histone deacetylase 3 represses proliferation and cancer stem-like properties in hepatocellular carcinoma cells.
Sun L; Wang L; Chen T; Shi Y; Yao B; Liu Z; Wang Y; Li Q; Liu R; Niu Y; Tu K; Liu Q
Cell Death Dis; 2020 Feb; 11(2):95. PubMed ID: 32024815
[TBL] [Abstract][Full Text] [Related]
6. Propofol exerts anticancer activity on hepatocellular carcinoma cells by raising lncRNA DGCR5.
Sun Y; Sun H
J Cell Physiol; 2020 Mar; 235(3):2963-2972. PubMed ID: 31538334
[TBL] [Abstract][Full Text] [Related]
7. LncRNA MEG3 repressed malignant melanoma progression via inactivating Wnt signaling pathway.
Li P; Gao Y; Li J; Zhou Y; Yuan J; Guan H; Yao P
J Cell Biochem; 2018 Sep; 119(9):7498-7505. PubMed ID: 29781534
[TBL] [Abstract][Full Text] [Related]
8. A positive feedback loop involving the LINC00346/β-catenin/MYC axis promotes hepatocellular carcinoma development.
Zhang N; Chen X
Cell Oncol (Dordr); 2020 Feb; 43(1):137-153. PubMed ID: 31691159
[TBL] [Abstract][Full Text] [Related]
9. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway.
Zheng Y; Jiang L; Hu Y; Xiao C; Xu N; Zhou J; Zhou X
BMC Cancer; 2017 Feb; 17(1):161. PubMed ID: 28241806
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA LINC00662 promotes M2 macrophage polarization and hepatocellular carcinoma progression via activating Wnt/β-catenin signaling.
Tian X; Wu Y; Yang Y; Wang J; Niu M; Gao S; Qin T; Bao D
Mol Oncol; 2020 Feb; 14(2):462-483. PubMed ID: 31785055
[TBL] [Abstract][Full Text] [Related]
11. NLRC5 regulates cell proliferation, migration and invasion in hepatocellular carcinoma by targeting the Wnt/β-catenin signaling pathway.
Peng YY; He YH; Chen C; Xu T; Li L; Ni MM; Meng XM; Huang C; Li J
Cancer Lett; 2016 Jun; 376(1):10-21. PubMed ID: 26975630
[TBL] [Abstract][Full Text] [Related]
12. Silencing of lemur tyrosine kinase 2 restricts the proliferation and invasion of hepatocellular carcinoma through modulation of GSK-3β/Wnt/β-catenin signaling.
Zhao G; Song Y; Dong L; Shi H; Li H; Yang L; Wang J
Biochem Biophys Res Commun; 2019 Oct; 517(4):722-728. PubMed ID: 31395338
[TBL] [Abstract][Full Text] [Related]
13. Piplartine suppresses proliferation and invasion of hepatocellular carcinoma by LINC01391-modulated Wnt/β-catenin pathway inactivation through ICAT.
Fan X; Song J; Zhao Z; Chen M; Tu J; Lu C; Wu F; Zhang D; Weng Q; Zheng L; Xu M; Ji J
Cancer Lett; 2019 Sep; 460():119-127. PubMed ID: 31207322
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA SNHG5 promotes human hepatocellular carcinoma progression by regulating miR-26a-5p/GSK3β signal pathway.
Li Y; Guo D; Zhao Y; Ren M; Lu G; Wang Y; Zhang J; Mi C; He S; Lu X
Cell Death Dis; 2018 Aug; 9(9):888. PubMed ID: 30166525
[TBL] [Abstract][Full Text] [Related]
15. DGCR5 promotes cancer stem cell-like properties of radioresistant laryngeal carcinoma cells by sponging miR-506 via Wnt pathway.
Tang T; Shan G
J Cell Physiol; 2019 Aug; 234(10):18423-18431. PubMed ID: 30980388
[TBL] [Abstract][Full Text] [Related]
16. LINC02273 Promotes Hepatocellular Carcinoma Progression via Retaining
Peng L; Ye R; Zhu X; Xie Y; Zhong B; Liu Y; Li H; Xie B
Biomed Res Int; 2022; 2022():9631036. PubMed ID: 35132378
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-298 represses hepatocellular carcinoma progression by inhibiting CTNND1-mediated Wnt/β-catenin signaling.
Cao N; Mu L; Yang W; Liu L; Liang L; Zhang H
Biomed Pharmacother; 2018 Oct; 106():483-490. PubMed ID: 29990836
[TBL] [Abstract][Full Text] [Related]
18. LncRNA SNHG7 accelerates the proliferation, migration and invasion of hepatocellular carcinoma cells via regulating miR-122-5p and RPL4.
Yang X; Sun L; Wang L; Yao B; Mo H; Yang W
Biomed Pharmacother; 2019 Oct; 118():109386. PubMed ID: 31545291
[TBL] [Abstract][Full Text] [Related]
19. DUXAP10 inhibition attenuates the proliferation and metastasis of hepatocellular carcinoma cells by regulation of the Wnt/β-catenin and PI3K/Akt signaling pathways.
Han K; Li C; Zhang X; Shang L
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30996112
[TBL] [Abstract][Full Text] [Related]
20. Involvement of H19/miR-326 axis in hepatocellular carcinoma development through modulating TWIST1.
Wei LQ; Li L; Lu C; Liu J; Chen Y; Wu H
J Cell Physiol; 2019 Apr; 234(4):5153-5162. PubMed ID: 30362512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
